ARCHIVED


Medical Policy

Policy Num:       09.003.007
Policy Name:     CONTACT LENSES FOR THE PEDIATRIC POPULATION 
Policy ID:          [09.003.007][Ar L M+ P+][0.00.00]


Last Review:       November 10, 2021
Next Review:      N/A
Issue:                   November, 2021

Archived

Related Policies: N/A

CONTACT LENSES FOR THE PEDIATRIC POPULATION 

Popultation Reference No. Populations Interventions Comparators Outcomes
1 Individuals:
  • with congenital aphakia
Interventions of interest are:
  • Use of Rx contact lenses
Comparators of interest are:
  • Use of Rx glasses and other therapies

Relevant outcomes include:

  • Better corrected vision
  • Promote wound healing
  • Correct refractive errors that cannot be corrected otherwise.
     
2 Individuals:
  • with acquired aphakia after cataract surgery (adult or pediatric)
Interventions of interest are:
  • Use of Rx contact lenses
Comparators of interest are:
  • Use of Rx glasses and other therapies

Relevant outcomes include:

  • Better corrected vision
  • Promote wound healing
  • Correct refractive errors that cannot be corrected otherwise.
     
3 Individuals:
  • with irregular corneas / corneal scarring when vision cannot be corrected with glasses 
Interventions of interest are:
  • Use of Rx contact lenses
Comparators of interest are:
  • Use of Rx glasses and other therapies

Relevant outcomes include:

  • Better corrected vision
  • Promote wound healing
  • Correct refractive errors that cannot be corrected otherwise.
     
4 Individuals:
  • with corneal ulcer / erosion or keratitis
Interventions of interest are:
  • Use of Rx contact lenses
Comparators of interest are:
  • Use of Rx glasses and other therapies

Relevant outcomes include:

  • Better corrected vision
  • Promote wound healing
  • Correct refractive errors that cannot be corrected otherwise.
     
5 Individuals:
  • with refractive errors that cannot be corrected at a sharpness level of 20/40 with glasses.
Interventions of interest are:
  • Use of Rx contact lenses
Comparators of interest are:
  • Use of Rx glasses and other therapies

Relevant outcomes include:

  • Better corrected vision
  • Promote wound healing
  • Correct refractive errors that cannot be corrected otherwise.
     
6 Individuals:
  • with amblyopia- when cannot be corrected otherwise
Interventions of interest are:
  • Use of Rx contact lenses
Comparators of interest are:
  • Use of Rx glasses and other therapies

Relevant outcomes include:

  • Better corrected vision
  • Promote wound healing
  • Correct refractive errors that cannot be corrected otherwise.
     
7 Individuals:
  • with albinism - as an alternative to polarized glasses to reduce sensitivity to light 
Interventions of interest are:
  • Use of Rx contact lenses
Comparators of interest are:
  • Use of Rx glasses and other therapies

Relevant outcomes include:

  • Alternative to polarized glasses to reduce sensitivity to light
  • Aesthetical alternative to eye patches
  • Correct refractive errors that can be corrected with glasses..
8 Individuals:
  • with albinism and severe photophobia
Interventions of interest are:
  • Use of Rx contact lenses
Comparators of interest are:
  • Use of Rx glasses and other therapies

Relevant outcomes include:

  • Alternative to polarized glasses to reduce sensitivity to light
  • Aesthetical alternative to eye patches
  • Correct refractive errors that can be corrected with glasses..
9 Individuals:
  • with amblyopia- as an alternative to eye patches therapy / traditional pathing of the eye / occlusion
Interventions of interest are:
  • Use of Rx contact lenses
Comparators of interest are:
  • Use of Rx glasses and other therapies

Relevant outcomes include:

  • Alternative to polarized glasses to reduce sensitivity to light
  • Aesthetical alternative to eye patches
  • Correct refractive errors that can be corrected with glasses..
10 Individuals:
  • with correction of refractive errors instead of glasses, except as indicated.
Interventions of interest are:
  • Use of Rx contact lenses
Comparators of interest are:
  • Use of Rx glasses and other therapies

Relevant outcomes include:

  • Alternative to polarized glasses to reduce sensitivity to light
  • Aesthetical alternative to eye patches
  • Correct refractive errors that can be corrected with glasses..

Summary

It is estimated that 40.9 million people over the age of 18 in the United States (one in six adults) wear contact lenses, 93 percent wear soft lenses and the rest have gas-permeable lenses.

Contact lenses can be classified by their composition material, time of use, total time of use, permeability, water content, and type of correction. With many types of new lenses available, there are alternatives to help most patients achieve the use of comfortable lenses with clear vision. New types of contact lenses are being introduced continuously with the intention of reducing the risks of infection, inflammation and trauma of the conjunctiva and maximize vision correction and comfort of use

Soft lenses are made of different plastic polymers that absorb water (hydrophilic). These materials differ in terms of oxygen permeability (expressed in Dk units, where D is diffusion and k for solubility), water content (which varies between 20 and 70 percent water by weight), quality of the surface (wettability), ultraviolet absorption, and structural consistency (rigidity or modulus). The Food and Drug Administration of the United States (FDA) has developed a classification system for soft lenses.

The maintenance of a smooth and transparent refraction anterior surface is fundamental for good vision. A complex interaction between the cornea and the conjunctival epithelium, the tear film, and the overlapping eyelids offers protection against infection and scarring. Noninfectious complications are minimized with a contact lens with an adjustment that is both based on the pre-corneal tear film and moves just enough to allow good fluid and gas exchange, thereby functioning as a de facto extension of the ocular surface.

Objective

N/A

Policy Statements

Contact lenses are considered for payment for any of the following indications:

A. Congenital aphakia

B. Acquired aphakia after cataract surgery (adult or pediatric);

C. Irregular corneas / corneal scarring when vision cannot be corrected with glasses (for example, keratoconus, after corneal graft surgery, after corneal infection);

D. As a corneal dressing to promote wound healing (eg, corneal ulcer / erosion, keratitis);

E. Refractive errors that cannot be corrected at a sharpness level of 20/40 with glasses.

F. Amblyopia when cannot be corrected otherwise.

Contact lenses are not considered for payment for the following conditions:        

A. Albinism - as an alternative to polarized glasses to reduce sensitivity to light or severe photophobia;

B. Amblyopia- as an alternative to eye patches therapy / traditional pathing of the eye / occlusion or

C. Prior authorization in the correction of refractive errors instead of glasses, except as indicated above.

Policy Guidelines

Preauthorization is required for the entire contact lens service.

Contact lenses used in the treatment of an eye medical condition covered by the benefit of eye care and low vision services for Medicaid, Family Health Plus and Child Health Plus members.

   a. Contact lenses for Medicaid members are eligible for coverage once every 24 months, unless there has been a change in vision that requires a change in prescription or the lenses have been lost or damaged.

   b. Contact lenses for Family Health Plus members are eligible for coverage once every 24 months.

   c. Contact Lenses for Child Heath Plus members are eligible for coverage once every 12 months

Multiple contact lens changes may be necessary in pediatric patients with aphakia whether acquired or congenital.

Contact lens application must include all the following characteristics:

   a. documentation of medical necessity

   b. better corrected vision with and without the lenses

   c. better corrected vision with and without contact lenses

   d. date of the last complete examination of the eyes

   e. refractive error.

Benefit Application

BlueCard/National Account Issues

N/A

Background

N/A

Regulatory Status

N/A

Rationale

Population Reference No. 1-6 Policy Statement

 For individuals with:

1) congenital aphakia,

2) acquired aphakia after cataract surgery (adult or pediatric),

3) irregular corneas or corneal scarring when vision cannot be corrected with glasses,

4) corneal ulcer or erosion or keratitis,

5) refractive errors that cannot be corrected at a sharpness level of 20/40 with glasses,

6) amblyopia when cannot be corrected otherwise treated with Rx contact lenses.

Relevant outcomes include better corrected vision, promote wound healing and correct refractive errors that cannot be corrected otherwise. The evidence is sufficient to determine that the technology results in a meaningful improvement in the net health outcome.

Population Reference No. 1-6 Policy Statement [X] MedicallyNecessary [ ] Investigational [ ] Not Medically Necessary

Population Reference No. 7-10  Policy Statement

For individuals with:

7) albinism (as an alternative to polarized glasses to reduce sensitivity to ligh)t

8) albinism (with severe photophobia),

9) amblyopia (as an alternative to eye patches therapy / traditional pathing of the eye / occlusion),

10) correction of refractive errors instead of glasses, except as indicated treated with Rx contact lense. 

Evidence suggest no additional medical benefit of using this technology when compared to other therapies available.

Population Reference No. 7-10 Policy Statement [ ] MedicallyNecessary [ ] Investigational [X] Not Medically Necessary

Supplemental Information

N/A

Practice Guidelines and Position Statements

N/A

Medicare National Coverage

N/A

References

1.         Cope JR, Collier SA, Rao MM, et al. Contact Lens Wearer Demographics and Risk Behaviors for Contact Lens-Related Eye Infections--United States, 2014. MMWR Morb Mortal Wkly Rep 2015; 64:865.

2.         Dart JK, Radford CF, Minassian D, et al. Risk factors for microbial keratitis with contemporary contact lenses: a case-control study. Ophthalmology 2008; 115:1647

Codes

Codes Number Description
HCPCS V2599 Contact lens, other type
ICD-10-CM H16.001-H16.003 Unspecified corneal ulcer (code range)
  H16.011-H16.013 Central corneal ulcer (code range)
  H16.021-H16.023 Ring corneal ulcer (code range)
  H16.031-H16.033 Corneal ulcer with hypopyon (code range)
  H16.041-H16.043 Marginal corneal ulcer (code range)
  H16.051-H16.053 Mooren's corneal ulcer (code range)
  H16.061-H16.063 Mycotic corneal ulcer (code range)
  H16.071-H16.073 Perforated corneal ulcer (code range)
  H16.101-H16.103 Other and unspecified superficial keratitis without conjunctivitis (code range)
  H16.111-H16.113 Macular keratitis (code range)
  H16.121-H16.123 Filamentary keratitis (code range)
  H16.131-H16.133 Photokeratitis (code range)
  H16.141-H16.143 Punctate keratitis (code range)
  H17.01-H17.03 Adherent leukoma (code range)
  H17.11-H17.13 Central corneal opacity (code range)
  H17.811-H17.813 minor opacity of cornea (code range)
  H17.821-H17.823 Peripheral opacity of cornea (code range)
  H17.89 Other corneal scars and opacities
  H17.9 Unspecified corneal scar and opacity
  H18.601-H18.603 Keratoconus, unspecified (code range)
  H18.611-H18.613 Keratoconus, stable (code range)
  H18.621-H18.623 Keratoconus, unstable (code range)
  H18.711-H18.713 Corneal ectasia (code range)
  H18.721-H18.723 Corneal staphyloma (code range)
  H18.731-H18.733 Descemetocele (code range)
  H18.791-H18.793 Other corneal deformities
  H25.011-H25.013 Age-related cataract (code range)
  H25.031-H25.033 Anterior subcapsular polar age-related cataract (code range)
  H25.041-H25.043 Posterior subcapsular polar age-related cataract (code range)
  H25.091-H25.093 Other age-related incipient cataract (code range)
  H25.11-H25.13 Age-related nuclear cataract (code range)
  H25.21-H25.23 Age-related cataract, morgagnian type (code range)
  H25.811-H25.813 Combined forms of age-related cataract (code range)
  H25.89 Other age-related cataract
  H25.9 Unspecified age-related cataract
  H26.001-H26.003 Infantile and juvenile cataract (code range)
  H26.011-H26.013 Unspecified infantile and juvenile cataract (code range)
  H26.031-H26.033 Infantile and juvenile nuclear cataract (code range)
  H26.041-H26.043 Anterior subcapsular polar infantile and juvenile cataract (code range)
  H26.051-H26.053 Posterior subcapsular polar infantile and juvenile cataract (code range)
  H26.061-H26.063 Combined forms of infantile and juvenile cataract (code range)
  H26.09 Other infantile and juvenile cataract
  H26.9 Unspecified cataract
  H27.01-H27.03 Aphakia (code range)
  Q12.3 Congenital aphakia
  H53.011-H53.013 Deprivation amblyopia (code range)
  H53.021-H53.023 Refractive amblyopia (code range)
  H53.031-H53.033 Strabismic amblyopia (code range)

Appplicable Modifiers

Some modifiers

Policy History

Date Action Description
11/10/2021 Annual Revision - Archived  Policy reviewed at Physician Advisory Board. No changes in policy statement. Policy approved for archival.
11/11/2020 Annual Revision     Policy reviewed at Provider Advisory Committee. No changes in policy statement.
11/14/2019 Annual Revision Policy reviwed at Provider Advisory Committee. No changes.
11/14/2018 Review added amblyopia PICO and code range. Edited policy statement.  Policy reviwed at Provider Advisory Committee 14 nov 2018
03/29/17    
06/10/2016    
06/08/2016    
04/01/16 New Policy